96 related articles for article (PubMed ID: 7583587)
1. Human endothelial cell damage by neutrophil-derived cathepsin G. Role of cytoskeleton rearrangement and matrix-bound plasminogen activator inhibitor-1.
Iacoviello L; Kolpakov V; Salvatore L; Amore C; Pintucci G; de Gaetano G; Donati MB
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):2037-46. PubMed ID: 7583587
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin G--induced release of PAI-1 in the culture medium of endothelial cells: a new thrombogenic role for polymorphonuclear leukocytes?
Pintucci G; Iacoviello L; Castelli MP; Amore C; Evangelista V; Cerletti C; Donati MB
J Lab Clin Med; 1993 Jul; 122(1):69-79. PubMed ID: 8320493
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin G, a polymorphonuclear cell protease, affects the fibrinolytic system by releasing PAI-1 from endothelial cells and platelets.
Pintucci G; Iacoviello L; Amore C; Evangelista V; Cerletti C; Donati MB
Ann N Y Acad Sci; 1992 Dec; 667():286-8. PubMed ID: 1309048
[No Abstract] [Full Text] [Related]
4. Neutrophil derived cathepsin G induces potentially thrombogenic changes in human endothelial cells: a scanning electron microscopy study in static and dynamic conditions.
Kolpakov V; D'Adamo MC; Salvatore L; Amore C; Mironov A; Iacoviello L; Donati MB
Thromb Haemost; 1994 Jul; 72(1):140-5. PubMed ID: 7974362
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil cathepsin G modulates platelet P-selectin expression and inhibits P-selectin-mediated platelet-neutrophil adhesion.
Ilton MK; Taylor ML; Misso NL; Thompson PJ; Hung J
Clin Sci (Lond); 1998 Apr; 94(4):437-45. PubMed ID: 9640350
[TBL] [Abstract][Full Text] [Related]
6. Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors.
Stefansson S; Yepes M; Gorlatova N; Day DE; Moore EG; Zabaleta A; McMahon GA; Lawrence DA
J Biol Chem; 2004 Jul; 279(29):29981-7. PubMed ID: 15131125
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil cathepsin G increases transendothelial albumin flux.
Peterson MW
J Lab Clin Med; 1989 Mar; 113(3):297-308. PubMed ID: 2926238
[TBL] [Abstract][Full Text] [Related]
8. Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase.
Bonnefoy A; Legrand C
Thromb Res; 2000 May; 98(4):323-32. PubMed ID: 10822079
[TBL] [Abstract][Full Text] [Related]
9. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
Renesto P; Ferrer-Lopez P; Chignard M
Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
[TBL] [Abstract][Full Text] [Related]
10. Human neutrophil cathepsin G is a potent platelet activator.
LaRosa CA; Rohrer MJ; Benoit SE; Rodino LJ; Barnard MR; Michelson AD
J Vasc Surg; 1994 Feb; 19(2):306-18; discussion 318-9. PubMed ID: 7509416
[TBL] [Abstract][Full Text] [Related]
11. Polymorphonuclear leukocyte lysosomal proteases, cathepsins B and D affect the fibrinolytic system in human umbilical vein endothelial cells.
Kimura Y; Yokoi-Hayashi K
Biochim Biophys Acta; 1996 Jan; 1310(1):1-4. PubMed ID: 9244167
[TBL] [Abstract][Full Text] [Related]
12. Endothelium-dependent relaxation induced by cathepsin G in porcine pulmonary arteries.
Glusa E; Adam C
Br J Pharmacol; 2001 Jun; 133(3):422-8. PubMed ID: 11375259
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil cathepsin G increases calcium flux and inositol polyphosphate production in cultured endothelial cells.
Peterson MW; Gruenhaupt D; Shasby DM
J Immunol; 1989 Jul; 143(2):609-16. PubMed ID: 2544647
[TBL] [Abstract][Full Text] [Related]
14. Binding of mutant tissue-type plasminogen activators to human endothelial cells and their extracellular matrix.
Fukao H; Ueshima S; Okada K; Matsuo O
Life Sci; 2000; 66(25):2473-87. PubMed ID: 10894090
[TBL] [Abstract][Full Text] [Related]
15. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial cell monolayer formed on membrane filter potentiates the defense against tumor cell invasion by treatment with brefeldin A.
Soeda S; Honda O; Shimeno H
Cancer Lett; 1996 Nov; 108(1):49-54. PubMed ID: 8950208
[TBL] [Abstract][Full Text] [Related]
17. [Tumor necrosis factor-α promote permeability of human umbilical vein endothelial cells via activating RhoA-ERK1/2 pathway].
Yan CH; Yu HB; Huang MF; Li J; Zhang XL; Han YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):531-7. PubMed ID: 21924080
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-mediated increased permeability of microcarrier-cultured endothelial monolayers: a model for the in vitro study of neutrophil-dependent mediators of vasopermeability.
Killackey JJ; Killackey BA
Can J Physiol Pharmacol; 1990 Jul; 68(7):836-44. PubMed ID: 1696515
[TBL] [Abstract][Full Text] [Related]
19. Activation of neutrophil collagenase by cathepsin G.
Capodici C; Muthukumaran G; Amoruso MA; Berg RA
Inflammation; 1989 Jun; 13(3):245-58. PubMed ID: 2546891
[TBL] [Abstract][Full Text] [Related]
20. Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells.
Yamamoto C; Kaji T; Sakamoto M; Kozuka H; Koizumi F
Thromb Res; 1994 Apr; 74(2):163-8. PubMed ID: 8029817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
